Navigation Links
Mastix Medica Introduces RenaGum™ - The First Medical Food Chewing Gum
Date:8/8/2013

Hunt Valley, MD (PRWEB) August 08, 2013

Mastix Medica, an innovative specialty manufacturer of dietary supplements and functional foods, has introduced RenaGum™, a novel medical food that helps patients with chronic kidney disease (CKD) maintain normal phosphate levels. RenaGum™ is specially formulated with chitosan, a well-known dietary, medical and environmental binding agent. Clinical studies show that chitosan released from chewing gum is an effective way to help maintain normal serum phosphate levels in CKD patients. RenaGum™ is made using natural ingredients, a non-allergenic chitosan from a vegetable source, not from shellfish, and is also Kosher certified. As a medical food product, RenaGum™ needs to be used under the supervision of a physician.

CKD is a growing health problem in the United States, with at least 20 million people in various stages of CKD including about 500,000 people with end-stage renal disease (ESRD) requiring hemodialysis. The two main causes of CKD are diabetes and high blood pressure accounting for up to 2/3 of all CKD cases. In people with CKD, and especially people with ESRD, one of the most important co-existing disorders is caused by increased levels of phosphorus (hyperphosphatemia) in the body.

Elevated serum phosphate levels are significantly associated with cardiovascular calcification and increased cardiac mortality. People with CKD and ESRD need to watch what they eat and drink and may take phosphate binder drugs that their doctor prescribes. These phosphate binder drugs are taken by patients during meals to prevent the absorption of phosphate in the digestive system from the food that is consumed.

“We are excited that Mastix Medica is introducing its first proprietary product, RenaGum™, to help people with CKD and ESRD maintain healthy phosphate levels,” commented Robert Estey, CEO of Mastix Medica. “RenaGum™ is a complimentary medical food that is chewed after a meal. It is designed to work with and complement a patient’s prescribed binder drugs at a different time and in a different way,” he continued. “RenaGum™ is not a replacement for a patient’s prescribed binder drugs. When the gum is chewed, the chitosan combines with phosphate found in saliva and then in the digestive tract after the saliva is swallowed,” Estey stated. “We expect RenaGum™ to become an integral component of the dietary management of kidney disease in patients with CKD and ESRD. Patients also like RenaGum™ because, as a chewing gum, it does not add to the heavy pill burden they already take with their meals,” concluded Mr. Estey.

More information about RenaGum™ can be found at http://www.renagum.com.

About Medical Foods
A Medical Food is an FDA-regulated product defined by Congress as part of the Orphan Drug Act. A Medical Food is specially formulated to be administered orally under the supervision of a physician and is intended for the specific dietary management of a disease or condition for which distinctive nutritional requirements, based on recognized scientific principles, are established by medical evaluation. Medical Foods have clinical studies supporting their use for specific conditions due to nutritional imbalances or deficiencies. Medical Foods are made with ingredients that are Generally Recognized As Safe (GRAS), the highest FDA standard of safety given to foods.

About Mastix Medica
Mastix Medica is a specialty manufacturer with expertise in unique tableted dosage forms like tableted chewing gum, lozenges and chewable tablets. Mastix Medica has a proprietary tableted gum manufacturing process that is unique in the industry. With a history in candy manufacturing, Mastix Medica has broad custom product development capabilities that have expanded into functional foods and dietary supplements, with particular expertise in hard to formulate tablet products, direct compression chewing gum and taste masking.

Read the full story at http://www.prweb.com/releases/2013/8/prweb11010469.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. California Physical Therapy Association Strongly Supports the "Promoting Integrity in Medicare Act" to Fight Self-Referral of Physical Therapist Services
2. China Medical Flat Panel Detector Market & Pressure Injector 2013 Research Reports Now Available at ReportsnReports.com
3. Global Pain Management Therapeutics Market to 2019 - Impact of Patent Expiries Offset by Demand for Neuropathic and Rheumatoid Pain Medications and Strong Pipeline: MarketResearchReports.Biz
4. Emerging Global Leader in Emergency Thermotherapy for Traumatic Brain Injury Expands US Operations to Site on the Campus of New York Medical College
5. Top Drug Testing Kit Distributor, Medical Disposables Corp. Joins the Florida Staffing Association
6. National Reference Laboratory, Warde Medical Laboratory to Showcase at 2013 AACC Clinical Lab Expo
7. Signal Genetics Announces Publication of BreastPRS™ Validation Study with Weill Cornell Medical College, New York
8. Saladax Biomedical Announces Addition to Leadership Team
9. Medical Device and Drug Research, New Life Science Webinar Hosted by Xtalks
10. Medical Power Supply Market Worth $866.8 Million By 2017
11. Tutela Launches Genesis II - Next Generation Wireless Medical Monitoring System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... June 27, 2016 /PRNewswire/ - BIOREM Inc. (TSX-V: BRM) ("Biorem" ... by its major shareholders, Clean Technology Fund I, LP ... States based venture capital funds which together ... (on a fully diluted, as converted basis), that they ... their entire equity holdings in Biorem to TUS Holdings ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... will join the faculty of the University of North Carolina Kenan-Flagler Business ... strategy and entrepreneurship at UNC Kenan-Flagler, with a focus on the school’s international ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... While the ... such as the Cary 5000 and the 6000i models are higher end machines that ... the height of the spectrophotometer’s light beam from the bottom of the cuvette holder. ...
(Date:6/23/2016)... June 23, 2016 /PRNewswire/ - FACIT has announced ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" ... commercialization of a portfolio of first-in-class WDR5 inhibitors ... such as WDR5 represent an exciting class of ... precision medicine for cancer patients. Substantial advances have ...
Breaking Biology Technology:
(Date:6/16/2016)... The global Biometric ... USD 1.83 billion by 2024, according to a ... proliferation and increasing demand in commercial buildings, consumer ... the market growth.      (Logo: ... of advanced multimodal techniques for biometric authentication and ...
(Date:6/9/2016)... 2016  Perkotek an innovation leader in attendance control systems is proud to announce ... for employers to make sure the right employees are actually signing in, and to ... ... ... ...
(Date:6/7/2016)... 7, 2016  Syngrafii Inc. and San Antonio ... that includes integrating Syngrafii,s patented LongPen™ eSignature "Wet" ... collaboration will result in greater convenience for SACU ... while maintaining existing document workflow and compliance requirements. ... Highlights: ...
Breaking Biology News(10 mins):